Valenzuela, Thomas F. III
Iaizzo, Paul A. http://orcid.org/0000-0002-7661-352X
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Institute for Engineering in Minnesota
Medtronic
Article History
Received: 6 April 2022
Accepted: 3 March 2023
First Online: 20 March 2023
Declarations
:
: LifeSource secured consent from the patient and his family. The Institutional Review Board at the University of Minnesota granted exemption from ethics approval, being the heart specimen was considered waste tissue donated for medical research.
: No animal studies were carried out by the authors for this article.
: Paul Iaizzo has a research contract and educational consulting role with Medtronic. Thomas Valenzuela is an employee of Medtronic.